左心室喷射率与恶化心力衰竭风险之间的U形关系
Hao-Chih Chang1,2,3, Wei-Ming Huang1,2,3, Liang-Yin Lin4
1Cardiovascular Center, Taipei Veterans General Hospital, Taipei, Taiwan.
European journal of heart failure
|October 21, 2025
概括
该研究发现左心室喷射分数 (LVEF) 和恶化的心力衰竭 (HF) 之间的U形联系. 超正常的LVEF (≥70%) 与高风险的HF事件相关,表明需要专门的管理.
科学领域:
- 心脏病学 心脏病学
- 心声回声扫描 (Echocardiography) 是一种心声回声扫描.
- 心脏衰竭研究研究
背景情况:
- 左心室喷射分数 (LVEF) 对于评估心脏功能至关重要.
- 以前的研究表明,LVEF与死亡率之间存在U形关系.
- 全谱LVEF与恶化心力衰竭 (HF) 风险之间的关联尚未确定.
研究的目的:
- 调查LVEF与恶化心力衰竭风险之间的关系.
- 分析LVEF值的全部范围及其对HF进展的影响.
- 为了确定与高频风险增加相关的特定LVEF范围.
主要方法:
- 分析了来自93,694名参与者的心声回声学数据.
- LVEF 分类为5%的间隔,从<20%到≥70%.
- 主要结局:综合所有原因死亡率或恶化HF;次要结局:所有原因死亡率,心血管死亡,恶化HF.
主要成果:
- 观察到LVEF与主要结果之间存在U形关联,LVEF风险最低为60-70%.
- 患有LVEF≥70%的参与者具有主要结局 (aHR1.12) 和恶化HF (aHR1.13) 的风险增加.
- 这种关联在各种人口统计和临床子组中保持一致.
结论:
- 左心室喷射分数表现出与恶化心力衰竭的U形关联.
- 超正常的LVEF (≥70%) 定义了一个高风险的HF恶化的表型.
- 针对超正常LVEF的个体,需要量身定制的管理策略.
相关概念视频
Pathophysiology of Heart Failure
2.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
Heart Failure II: Pathophysiology
707
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
707
Mitral Regurgitation I: Introduction
409
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
409
Heart Failure IV: Classification and Diagnostic Evaluation
317
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
317
Mitral Stenosis I: Introduction
453
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
453
Heart Failure V: Medical Management
215
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
215


